UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

A phase II clinical trial of fludarabine and cyclophosphamide followed by thalidomide for angioimmunoblastic T-cell lymphoma. An NCRI clinical trial. CRUK number C17050/A5320

Townsend, W; Johnson, RJ; Pottinger, BT; Counsell, N; Smith, P; Chadwick, H; Evans, K; ... Rudin, CE; + view all (2016) A phase II clinical trial of fludarabine and cyclophosphamide followed by thalidomide for angioimmunoblastic T-cell lymphoma. An NCRI clinical trial. CRUK number C17050/A5320. Leukemia & Lymphoma , 57 (9) pp. 2232-2234. 10.3109/10428194.2015.1133814. Green open access

[thumbnail of Counsell_AITL letter v2.pdf]
Preview
 Text
Counsell_AITL letter v2.pdf - Accepted Version
Download (436kB) | Preview
Type: Article
Title: A phase II clinical trial of fludarabine and cyclophosphamide followed by thalidomide for angioimmunoblastic T-cell lymphoma. An NCRI clinical trial. CRUK number C17050/A5320
Open access status: An open access version is available from UCL Discovery
DOI: 10.3109/10428194.2015.1133814
Publisher version: https://doi.org/10.3109/10428194.2015.1133814
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > CRUK Cancer Trials Centre
URI: https://discovery.ucl.ac.uk/id/eprint/10093234
Downloads since deposit
101Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item